Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
98%
Liver Transplantation
94%
Cirrhosis
83%
Liver Transplant Recipients
81%
Obese Subjects
78%
Hepatitis C Virus
67%
Transjugular Intrahepatic Portosystemic Shunt
67%
Liver
60%
Hepatic Fat
56%
Liver Disease
48%
Adipose Tissue
42%
Lipoprotein Kinetics
39%
United States
39%
Clinical Outcomes
39%
Renal Disease
38%
Low-density Lipoprotein
37%
Orthotopic Liver Transplantation
37%
Hepatitis C
37%
Obese Men
35%
Hepatitis C Virus Infection
34%
Randomized Placebo-controlled Trial
33%
Nonalcoholic Steatohepatitis
33%
Primary Liver Cancer
33%
Insulin Action
33%
Chronic Kidney Disease
33%
Hepatorenal Syndrome
33%
Alzheimer's Disease
33%
Weight Loss
30%
Portal Hypertension
29%
Low-density Lipoprotein Triglyceride
29%
Solid Organ Transplantation
28%
Confidence Interval
28%
Fibrosis
27%
Sofosbuvir
27%
Insulin Resistance
25%
Hepatocellular Carcinoma
25%
Patient Survival
25%
Graft Survival
24%
Gastric Bypass Surgery
23%
Pretransplant
23%
Decompensated Cirrhosis
23%
Chronic Liver Disease
23%
Insulin Sensitivity
23%
Fatty Acids
22%
Cholangiocarcinoma
21%
Treatment Options
21%
Adult Patients
21%
Liver Tissue
20%
Older Donors
20%
MELD Score
20%
Medicine and Dentistry
Liver Graft
100%
Liver Transplantation
91%
Liver Cirrhosis
81%
Nonalcoholic Fatty Liver
77%
Liver Disease
54%
Transjugular Intrahepatic Portosystemic Shunt
50%
Hepatitis C
48%
Portal Hypertension
46%
Hepatitis C Virus
45%
Liver Cancer
33%
Chronic Kidney Disease
33%
Hepatitis B Virus
33%
Solid Organ Transplantation
33%
Cholangiocarcinoma
29%
Diseases
28%
Hepatocellular Carcinoma
27%
Combination Therapy
27%
Liver Injury
24%
Graft Survival
24%
Adverse Event
23%
Triacylglycerol
21%
Gastric Bypass Surgery
21%
COVID-19
20%
Chronic Hepatitis B
20%
Placebo
20%
Adipose Tissue
19%
Antiviral Therapy
19%
Hyperbilirubinemia
19%
Antivirus Agent
18%
Very Low Density Lipoprotein
17%
Yttrium 90
16%
Organ Transplantation
16%
Radioembolization
16%
Small Interfering RNA
16%
Hereditary Hemorrhagic Telangiectasia
16%
Emricasan
16%
Acylglycerol Palmitoyltransferase
16%
Liver Dysfunction
16%
Stereotactic Body Radiation Therapy
16%
Virus Capsid
16%
Systolic Function
16%
Ideal Body Weight
16%
Fistula
16%
Medicare
16%
Lipidomics
16%
Shared Decision Making
16%
Sarcoidosis
16%
Hepatopulmonary Syndrome
16%
Medium Chain Fatty Acid
16%
Rapamycin
16%
